Abstract
The Trp64Arg amino-acid variant of the β3 adrenoreceptor gene may be associated with a genetic predisposition to human obesity and related disorders, including type 2 diabetes mellitus. This relationship has been reported in various ethnic groups, however it was not extensively studied in Polish population. Therefore, the aim of the study was to investigate the association of Trp64Arg polymorphism of the β3 adrenergic receptor gene with overweight and type 2 diabetes mellitus in polish subjects. The Trp64Arg polymorphism was determined by PCR-based MspI restriction fragment length polymorphism (PCR-RFLP). The study population consisted of 358 subjects, among whom 200 were diagnosed as overweight (BMI > 27 kg/m2). Among overweight subjects 111 presented with type 2 diabetes mellitus and 89 with normal glucose metabolism. All study participants were unrelated Caucasians and inhabited the city of Lodz, Poland. The frequency of the Arg allele did not differ significantly between overweight and normal weight patients (13 % vs. 11 %, OR 1.17, CI 0.74 - 1.85). The same applied to overweight diabetic patients vs. overweight patients without diabetes mellitus (13 % vs. 13 %, OR 0.97, CI 0.54 - 1.76). The obtained results suggest no association between Trp64Arg polymorphism of the β3-AR gene and the incidence of overweight and type 2 diabetes mellitus in Polish population.
Key words
β3-adrenergic receptor - genetic polymorphism - overweight - type 2 diabetes mellitus
References
-
1
Allison D B, Heo M, Faith M S, Pietrobelli A.
Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index.
Int J Obes Relat Metab Disord.
1998;
22
559-566
-
2
Arch J R, Kaufmann A J.
Beta 3 and atypical beta-adrenoreceptors.
Med Res Rev.
1993;
13
663-729
-
3
Arner P.
The β3-adrenergic receptor - a cause and cure of obesity?.
N Engl J Med.
1995;
333
382-383
-
4
Birnbaumer M.
Mutations and diseases of G protein coupled receptors.
J Recept Signal Transduct Res.
1995;
15
131-160
-
5
Clement K, Vaisse C, Manning B S, Basdevant A, Guy-Grand B, Ruiz J, Silver K D, Shuldiner A R, Froguel P, Strosberg A D.
Genetic variations in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.
N Engl J Med.
1995;
333
352-354
-
6
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus .
Report of the expert committee on the diagnosis and classification of diabetes mellitus [from the American Diabetes Association, ADA].
Diabetes Care.
2002;
25 (Suppl 1)
S1-S20
-
7
Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Oga T, Ueda H, Shintani M, Fukuda M, Ogihara T.
Association of Trp64Arg mutation of the beta3-adrenergic receptor with NIDDM and body weight gain.
Diabetologia.
1996;
39
349-352
-
8
Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon Y C, Dionne F T, Oppert J M, Perusse L, Sjostrom L, Bouchard C.
The Trp64Arg mutation of the beta 3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts.
J Clin Invest.
1996;
98
2086-2093
-
9
Kurabayashi T, Carey D G, Morrison N A.
The beta3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population.
Diabetes.
1996;
45
1358-1363
-
10
Li L S, Lonnqvist F, Luthman H, Arner P.
Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects.
Diabetologia.
1996;
39
857-860
-
11
Lonnqvist F, Home A, Nilsell K, Hoffstedt J, Arner P.
A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
J Clin Invest.
1995;
95
1109-1116
-
12
Manraj M, Francke S, Hebe A, Ramjuttun U S, Froguel P.
Genetic and environmental nature of the insulin resistance syndrome in Indo-Mauritian subjects with premature coronary heart disease: contribution of β3-adrenoreceptor gene polymorphism and beta blockers on triglyceride and HDL concentrations.
Diabetologia.
2001;
44
115-122
-
13
Marti A, Corbalan M S, Martinez-Gonzalez M A, Martinez J A.
Trp64Arg polymorphism of the β3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle.
Diabetes Obes Metab.
2002;
4
428-430
-
14
Melis M G, Secchi G, Brizzi P, Severino C, Maioli M, Tonolo G.
The Trp64 Arg β3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects.
Clinical Science.
2002;
103
397-402
-
15
Mizuno K, Kanda Y, Kuroki Y, Watanabe Y.
The stimulation of β3-adrenoceptor causes phosphorylation of extracellular signal-regulated kinases 1 and 2 through a Gs- but not Gi-dependent pathway in 3T3-L1 adipocytes.
Eur J Pharmacol.
2000;
404
63-68
-
16
Moriarty M, Wing R R, Kuller L H, Ferrell R E.
Trp64Arg substitution in the β3-adrenergic receptor does not relate to body weight in healthy, premenopausal women.
Int J Obesity.
1996;
21
826-829
-
17
Muzzin P, Revelli J P, Kuhne F, Gocayne J D, McCombie W R, Venter J C, Giacobino J P, Fraser C M.
An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity.
J Biol Chem.
1991;
256
24053-24058
-
18
Rawson E S, Nolan A, Silver K, Shuldiner A R, Poehlman E T.
No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women.
Metabolism.
2002;
51
801-805
-
19
Strazzullo P, Iacone R, Siani A, Cappucino F P, Russo O, Barba G, Barbato A, D'Elia L, Trevisian M, Farinaro E.
Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study.
J Hypertens.
2001;
19
399-406
-
20
Tataranni P A, Pratley R, Shuldiner A, Ravussin E.
Beta3-adrenergic receptor gene variant and lipid metabolism in Pima Indians.
Diabetologia.
1997;
40
123-124
-
21
Tonolo G, Melis M G, Secchi G, Atzeni M M, Angius M F, Carboni A, Ciccarese M, Malavasi A, Maioli M.
Association of Trp64Arg beta3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.
J Hypertens.
1999;
17
33-38
-
22
Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H.
Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lypolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
Diabetes.
1999;
48
117-120
-
23
Walston J, Silver K, Bogardus C, Knowler W C, Celi F S, Austin S, Manning B, Strosberg A D, Stern M P, Raben N.
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.
N Engl J Med.
1995;
333
343-347
-
24
Widen E, Lehto M, Kanninen T, Walston J, Shuldiner A R, Groop L C.
Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.
N Engl J Med.
1995;
333
348-351
-
25
Yen T T.
Beta-agonists as antiobesity, antidiabetic and nutritient partitioning agents.
Obes Res.
1995;
3
531S-536S
MD, PhD Jacek Kasznicki
Department of Clinical Pharmacology
Medical University of Lodz
Lodz
Poland
Email: jkasznicki@up.pl
